York Capital Management Global Advisors’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-302,675
Closed -$35.7M 75
2020
Q4
$35.7M Sell
302,675
-1,149,195
-79% -$133M 3.52% 4
2020
Q3
$161M Buy
1,451,870
+103,973
+8% +$11.2M 9% 2
2020
Q2
$138M Buy
1,347,897
+496,423
+58% +$53.1M 9.09% 1
2020
Q1
$91.9M Sell
851,474
-250,689
-23% -$28.8M 5.47% 5
2019
Q4
$128M Buy
1,102,163
+50,725
+5% +$5.87M 7.4% 3
2019
Q3
$120M Sell
1,051,438
-77,279
-7% -$7.68M 5.58% 7
2019
Q2
$108M Buy
1,128,717
+137,484
+14% +$12.9M 4.36% 7
2019
Q1
$90.5M Sell
991,233
-216,636
-18% -$17.7M 4.05% 7
2018
Q4
$91.7M Buy
1,207,869
+40,226
+3% +$2.96M 5.57% 5
2018
Q3
$93.4M Buy
1,167,643
+339,905
+41% +$31.7M 2.95% 10
2018
Q2
$82.2M Buy
827,738
+486,122
+142% +$42M 2% 13
2018
Q1
$27.7M Buy
341,616
+180,769
+112% +$14.6M 0.62% 34
2017
Q4
$12.7M Buy
160,847
+130,549
+431% +$10.9M 0.31% 41
2017
Q3
$2.8M Sell
30,298
-49,931
-62% -$4.8M 0.06% 66
2017
Q2
$9.07M Sell
80,229
-16,315
-17% -$1.82M 0.19% 52
2017
Q1
$9.67M Buy
96,544
+37,269
+63% +$3.98M 0.23% 47
2016
Q4
$6.37M Buy
59,275
+10,587
+22% +$1.24M 0.17% 53
2016
Q3
$6.06M Sell
48,688
-119,275
-71% -$14.1M 0.19% 62
2016
Q2
$17.9M Buy
167,963
+143,770
+594% +$16.7M 0.45% 40
2016
Q1
$2.77M Buy
+24,193
New +$2.84M 0.06% 56

Other funds holding CBPO

York Capital Management Global Advisors's CBPO Position: Q1 2021 in Review

York Capital Management Global Advisors sold out of China Biologic Products Holdings, Inc. (CBPO) in Q1 2021, closing a stake of 302,675 shares — an estimated $35.7M sold.

York Capital Management Global Advisors first reported a position in CBPO in Q1 2016 and held it in 20 quarters. The position peaked at $161M in Q3 2020. 86 funds tracked by Wall St. Rank hold CBPO as of Q1 2021.

  • York Capital Management Global Advisors reported no remaining China Biologic Products Holdings, Inc. position as of Q1 2021 after selling out during the quarter.
  • York Capital Management Global Advisors sold 302,675 China Biologic Products Holdings, Inc. shares in Q1 2021, an estimated $35.7M.
  • York Capital Management Global Advisors first reported a position in China Biologic Products Holdings, Inc. in Q1 2016 and held it in 20 quarters.
  • York Capital Management Global Advisors's China Biologic Products Holdings, Inc. position peaked at $161M in Q3 2020.
  • 86 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q1 2021.

Based on York Capital Management Global Advisors's 13F filing for Q1 2021, filed 17 May 2021.